Coronavirus mutation is not increasing spread of infection : Study by UCL

▴ Coronavirus mutation is not increasing spread of infection : Study by UCL
University College London's Genetics Institute ran the study through 13000 coronavirus mutations

Coronavirus has not mutated to become more infectious, according to a scientific study that debunks a widespread theory.

Most coronavirus cases seen globally feature a specific genetic mutation called D614G which is different from the original strain that emerged in Wuhan last year and experts feared was more infectious than the original version.

But UCL researchers looked at more than 46,723 cases of Covid-19 from 99 countries and assessed how mutations appeared and if they altered transmissibility.

Scientists identified 12,706 total mutations in SARS-CoV-2 — the virus which causes Covid-19 — and none of them was found to boost infectivity.This includes D614G which is found on the spike of the coronavirus and allows it to bind to human cells, a mechanism which allows it to infect people.

Other academics doing lab studies, not genetic reviews, had previously found D614G made the virus more infectious but the UCL researchers believe it became dominant by chance, not by design.

They say their conclusions may disagree with previous findings due to different methodologies and that D614G became so prevalent because it was an early mutation which happened to get carried around the world in the early days of the pandemic, not because it is more infectious.

UCL scientists found the D614G mutation in 77.8 per cent of all cases but say it does not make the virus more infectious +3
UCL scientists found the D614G mutation in 77.8 per cent of all cases but say it does not make the virus more infectious

The study, published in the journal Nature Communications, explains mutations in coronaviruses can develop in three different ways.

These are mistakes resulting from copying errors as the virus replicates inside the human body; through interactions with other viruses infecting the same cell; and changes induced by the host's or a person's own immune system.

Most mutations to SARS-CoV-2 are due to the latter, the researchers discovered.

First and corresponding author Lucy van Dorp, of UCL Genetics Institute, added: 'Fortunately, we found that none of these mutations are making Covid-19 spread more rapidly, but we need to remain vigilant and continue monitoring new mutations, particularly as vaccines get rolled out.'

Based on a modelling of the virus's evolutionary tree, the scientists said they found no evidence any of the common mutations are increasing the virus's transmissibility.

Instead, they found most common mutations have a neutral impact on the virus, neither hindering or enhancing its ability to spread.

This includes D614G, which is by far the most common strain of coronavirus affecting humans worldwide.

In a bid to explain how D614G became so dominant if it is not by being more infectious, researchers Professor Francois Balloux and Dr Lucy van Dorp told MailOnline: 'The first genomes sampled were mostly of the 614D type, but we've been observing the D614G mutation since mid-January with the first reports in China.

'The increase in the frequency of the [original] 614G variant in places such as the UK or the US could be largely due to demographic processes (i.e. with the 614D and 614G variants being equally transmissible but not introduced at the same rate).

'For example, transmission in France and Northern Italy are known to have happened since Nov/Dec 2019.

'We do not have many early SARS-CoV-2 genomes from these populations, but 614G was likely common (if not dominant) in places such as Northern Italy from the start.

'Viral strains from these early epidemics have been introduced many times into other countries. For example there have been more than 1,000 introductions from abroad into the UK.

'The constant introduction of 614G strains could explain why we're seeing more of them now. As such, the 614G variant is likely to be a "neutral hitchhiker" on the lineages that spread worldwide rather than the driver of the spread.'

Story Source: https://www.dailymail.co.uk/sciencetech/article-8985537/Coronavirus-mutations-not-speeding-spread-say-scientists.html 

Tags : #Coronavirus #CoronavirusMutation #UCLGeneticsInstitute #NatureCommunications

About the Author


Team Medicircle

Related Stories

02 Apr

DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?

As the healthcare landscape evolves, initiatives like these will determine the future of medical care in the country.

View
01 Mar

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?

The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View
24 Feb

The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing System

The NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary.

View
24 Feb

The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West Africa

Stricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups.

View
21 Feb

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market.

View
19 Feb

Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery Wave

AIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed.

View
19 Feb

Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?

As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change.

View
12 Feb

First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis Specialist

Delayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025